Genmab — April 2021
-
Mornings - bemærker, at ledelsen hos Genmab har fået bemyndigelse til at udstede op til 5,5 mio. nye aktier frem til 2026... Pengekassen er jo også ved at være tom....
-
og mulighed for tilbagekøb af 500.000 akter til egenbeholdning (ej warrants)
-
-
@Vesterled - beløb er angivet i nominel størrelse DKK. Selskabskapitalen i Genmab er sammensat af 65 mio. aktier med en nominel værdi af 1 kr. Antal aktier jf. 7:49+7:53 er korrekt gengivet.
-
Analytiker om dansk biotekselskab: Det kan blive en gamechanger https://www.euroinvestor.dk/nyheder/analytiker-om-dansk-biotekselskab-det-kan-blive-en-gamechanger (in case you haven't heard Millionærklubben)
-
Thank you E L. A quick question. Do you know if a drug has ever been rejected after having been issued a priority review?
-
Ja bussen kørte 12 Marts da vi fik macd købssignal https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/91849_macd_buy_signal.png
-
E L and Sukker. No - my question was just about the historical relationship between the PR and the approval, as there must be some criteria met to obtain a PR. I realise that it potentially still can fail and that it, with good reason, still has to live up to the normal standards. Thank you both for replying. E L, no need to search. I trust your memory
-
Og tak for link Sukker
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind